NOVEMBER — LUNG CANCER AWARENESS MONTH. LET’S TALK ABOUT THE CAPABILITIES OF MODERN GENETIC DIAGNOSTICS

Today, lung cancer treatment is personalized therapy that is tailored based on the unique genetic characteristics of the tumor. To choose effective treatment, the doctor needs to determine the molecular profile of the tumor sample.

The National Medical Research Oncological Centre of the Ministry of Health of the Russian Federation provides patients diagnosed with lung cancer access to the most advanced diagnostic methods.

In addition to standard PCR tests, it is possible here, under the OMS policy and with a referral in the 057/u-04 format, to conduct an extended genetic study using two large gene panels:
1. DNA panel (637 genes) — searching for mutations in key genes such as EGFR, KRAS, BRAF, MET, HER2, as well as many others.
2. RNA panel (105 genes) — searching for gene fusions, including ALK, ROS1, RET, NTRK, and others.

Using these panels together gives the doctor the most complete picture and the ability to choose the appropriate targeted drug.

How can a patient undergo the examination?

1. Obtain a referral using form 057/u-04.
2. Make an appointment for a consultation with an oncologist at theP.Hertsen MORI and get a doctor’s recommendation for conducting a molecular genetic test for the lung cancer panel.
3. Contact the institute’s pathology department to arrange the paperwork for transferring tumor material to the genetic laboratory.
4. Await the result. The turnaround time for the test is 30 days.

Stay informed and act promptly!